This Nuclear Stock Is Down 46%, and It's a Screaming Buy

The market is not pricing a disagreement on the technology; it is pricing a timing mismatch. In the next 1-3 months, the key issue is that pre-revenue nuclear developers tend to re-rate only on hard de-risking events, not on narrative support, so sentiment can stay compressed even if the long-run thesis is intact. That favors businesses with already-monetized nuclear bottlenecks — especially fuel-cycle and enrichment exposure — over “future reactor” equity stories.

The second-order effect is that AI power demand does not have to wait for a new reactor platform to be solved. Hyperscalers will keep signing interim power solutions, which means the near-term winner is the incumbent generation stack and the supply chain around specialized fuel, licensing, and project execution, not necessarily the developer whose economics depend on first-of-a-kind deployment. If OKLO keeps sliding, it likely reflects the market applying a higher discount rate to a binary commercialization path, not a change in the end-market opportunity.

Contrarianly, the consensus may be underestimating how long regulation and customer procurement can take for novel nuclear designs. The thesis breaks if there is a visible catalyst path: NRC milestone acceleration, a binding take-or-pay contract, or an operating timetable that converts “optional” demand into bankable revenue. Absent that, every rally risks becoming a capital-markets event rather than a fundamental one.